Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02489305 · ClinicalTrials.gov registry record

Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD)

A clinical trial of Depressive Disorder, Major, sponsored by Janssen Research & Development.

Completed
Registry status
330
Enrollment target
20
Study locations

NCT02489305 is a study of Depressive Disorder, Major that has completed, run by Janssen Research & Development. The registered enrollment target is 330 participants, above the 236-participant average among 52 other Depressive Disorder, Major trials with a reported enrollment target (40% higher). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02489305, a study of Depressive Disorder, Major, has completed, sponsored by Janssen Research & Development.

COMPLETED
Registry status
330 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to identify if there are self-reported or objective measures related to mood parameters that can predict near-term relapse (within 1 month or at another identified time point before meeting the criteria for relapse) or early symptomatic changes indicative of relapse prodrome in major depressive disorder (MDD).

Conditions Studied

Depressive Disorder, Major

Study Locations (20)

California

  • - Glendale
  • - Oceanside
  • - San Diego
  • - Sherman Oaks
  • - Stanford

Florida

  • - Jacksonville
  • - Orlando
  • - Tampa

Illinois

  • - Chicago
  • - Skokie
  • - Springfield

Alabama

  • - Birmingham

Connecticut

  • - Hartford

Georgia

  • - Augusta

Iowa

  • - Iowa City

Kansas

  • - Wichita

Trial Details

FieldValue
Enrollment Target 330 participants
Start Date 2014-12-15
Est. Completion 2018-05-01

Sponsor

Janssen Research & Development

593 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02489305

The ClinicalTrials.gov registry entry for NCT02489305 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 236-participant average among 52 other Depressive Disorder, Major trials with a reported enrollment target (40% higher). The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depressive Disorder, Major appearing as the primary indexed condition, and to 0 interventions.

NCT02489305 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT02489305 about?

NCT02489305 is a clinical study titled "Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD)". The purpose of this study is to identify if there are self-reported or objective measures related to mood parameters that can predict near-term relapse (within 1 month or at another identified time point before meeting the criteria for relapse) or early symptomatic changes indicative of relapse prod...

What is the current status of trial NCT02489305?

This trial is currently completed. The enrollment target is 330 participants. The study started on 2014-12-15. Estimated completion is 2018-05-01.

What conditions does trial NCT02489305 study?

This clinical trial studies the following conditions: Depressive Disorder, Major.

Who is sponsoring clinical trial NCT02489305?

This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02489305 being conducted?

This trial has 20 study locations across Alabama, California, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depressive Disorder, Major

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Depressive Disorder, Major

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.